TLR8 and neoplasm: Activated TLR8 pathway remarkably reshapes the tumor immune microenvironment by decreasing infiltrating myeloid-derived suppressor cells (MDSCs), regulatory T cells (Tregs), and immunosuppressive markers, such as CTLA-4 [38].